Literature DB >> 28314915

[Cutaneous manifestations of sarcoidosis].

K Amschler1, C S Seitz2.   

Abstract

Skin manifestations of sarcoidosis occur in up to 30% of cases. This review summarizes and illustrates in detail the differences between specific and unspecific skin manifestations of sarcoidosis. Important differential diagnoses, such as tuberculosis, cutaneous lymphoma and syphilis have to be excluded. The indications for systemic treatment are primarily determined by the extent of organ involvement and also by the cosmetic impairment.

Entities:  

Keywords:  Epithelioid granuloma; Erythema nodosum; Lupus pernio; Löfgren syndrome; Skin

Mesh:

Year:  2017        PMID: 28314915     DOI: 10.1007/s00393-017-0290-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  37 in total

1.  The presence of foreign bodies does not exclude the diagnosis of sarcoidosis.

Authors:  J P Callen
Journal:  Arch Dermatol       Date:  2001-04

2.  [Sarcoidosis : Organ involvement, diagnosis, current treatment].

Authors:  B Weidenthaler-Barth; K Steinbrink; A Kümmel; E von Stebut
Journal:  Hautarzt       Date:  2015-07       Impact factor: 0.751

3.  Disfiguring papular sarcoidosis of the face: dramatic improvement with pimecrolimus.

Authors:  M La Placa; R Balestri; C Mega; L Fasano; S Nava; A Patrizi
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-07-30       Impact factor: 6.166

4.  A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis.

Authors:  Robert J Pariser; Joan Paul; Stefanie Hirano; Cyndi Torosky; Molly Smith
Journal:  J Am Acad Dermatol       Date:  2012-12-28       Impact factor: 11.527

5.  Cutaneous sarcoidosis successfully treated with topical tacrolimus.

Authors:  N Katoh; H Mihara; H Yasuno
Journal:  Br J Dermatol       Date:  2002-07       Impact factor: 9.302

Review 6.  Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists.

Authors:  Edwina Lamrock; Pam Brown
Journal:  Australas J Dermatol       Date:  2012-02-16       Impact factor: 2.875

Review 7.  Cutaneous Sarcoidosis.

Authors:  Karolyn A Wanat; Misha Rosenbach
Journal:  Clin Chest Med       Date:  2015-09-26       Impact factor: 2.878

8.  Erythema nodosum and associated diseases. A study of 129 cases.

Authors:  B Cribier; A Caille; E Heid; E Grosshans
Journal:  Int J Dermatol       Date:  1998-09       Impact factor: 2.736

9.  Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists.

Authors:  A-M Thielen; C Barde; J-H Saurat; E Laffitte
Journal:  Dermatology       Date:  2009-05-25       Impact factor: 5.366

10.  Prognostic value of skin lesions in sarcoidosis: clinical and histopathological clues.

Authors:  Tiago C Esteves; Gloria Aparicio; Berta Ferrer; Vicente Garcia-Patos
Journal:  Eur J Dermatol       Date:  2015 Nov-Dec       Impact factor: 3.328

View more
  1 in total

1.  [Under the skin-A special manifestation of a systemic granulomatous disease].

Authors:  N Ruffer; V Becker; I Kötter
Journal:  Z Rheumatol       Date:  2019-11       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.